Literature DB >> 11821948

The interaction of p53 with the nuclear matrix is mediated by F-actin and modulated by DNA damage.

Andrei L Okorokov1, Carlos P Rubbi, Su Metcalfe, Jo Milner.   

Abstract

The tumour suppressor protein p53 is localized in the cell nucleus where it serves to initiate cellular responses to a variety of stresses, particularly DNA damage and has the capacity to transactivate stress response genes. An emerging body of evidence indicates that its action is also exerted through direct protein-protein interactions. An approach to understanding p53 function has been to analyse its positioning in relation to nuclear structures and we have shown that p53 can associate with the nuclear matrix. A potential nuclear matrix component for this association is actin. Here we show that p53 interacts with nuclear F-actin and we map the domains involved in this interaction. Using fluorescence resonance energy transfer, we demonstrate that the partition of p53 between F-actin bound and unbound forms is not constant, but is modulated by the presence of DNA damage, which increases binding. Our results indicate that the dynamic interaction of p53 with the nuclear matrix has to be considered for a full understanding of the mechanisms of the p53-mediated cellular response to DNA damage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11821948     DOI: 10.1038/sj.onc.1205112

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  RUNX3 is involved in caspase-3-dependent apoptosis induced by a combination of 5-aza-CdR and TSA in leukaemia cell lines.

Authors:  Feng-Xian Zhai; Xiang-Fu Liu; Rui-Fang Fan; Zi-Jie Long; Zhi-Gang Fang; Ying Lu; Yong-Jiang Zheng; Dong-Jun Lin
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-18       Impact factor: 4.553

Review 2.  p53 regulation of podosome formation and cellular invasion in vascular smooth muscle cells.

Authors:  Alan S Mak
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

3.  Alteration of nuclear matrix-intermediate filament system and differential expression of nuclear matrix proteins during human hepatocarcinoma cell differentiation.

Authors:  Jian Tang; Jing-Wen Niu; Dong-Hui Xu; Zhi-Xing Li; Qi-Fu Li; Jin-An Chen
Journal:  World J Gastroenterol       Date:  2007-05-28       Impact factor: 5.742

4.  Subnuclear targeting of the Runx3 tumor suppressor and its epigenetic association with mitotic chromosomes.

Authors:  Sandhya Pande; Syed A Ali; Christopher Dowdy; Sayyed K Zaidi; Kosei Ito; Yoshiaki Ito; Martin A Montecino; Jane B Lian; Janet L Stein; Andre J van Wijnen; Gary S Stein
Journal:  J Cell Physiol       Date:  2009-03       Impact factor: 6.384

5.  NMPdb: Database of Nuclear Matrix Proteins.

Authors:  Sven Mika; Burkhard Rost
Journal:  Nucleic Acids Res       Date:  2005-01-01       Impact factor: 16.971

6.  Gain of function mutant p53 proteins cooperate with E2F4 to transcriptionally downregulate RAD17 and BRCA1 gene expression.

Authors:  Fabio Valenti; Federica Ganci; Giulia Fontemaggi; Andrea Sacconi; Sabrina Strano; Giovanni Blandino; Silvia Di Agostino
Journal:  Oncotarget       Date:  2015-03-20

7.  The Nuclear Matrix Protein, NRP/B, Acts as a Transcriptional Repressor of E2F-mediated Transcriptional Activity.

Authors:  Jina Choi; Eun Sung Yang; Kiweon Cha; John Whang; Woo-Jung Choi; Shalom Avraham; Tae-Aug Kim
Journal:  J Cancer Prev       Date:  2014-09

8.  Cofilin-mediated Neuronal Apoptosis via p53 Translocation and PLD1 Regulation.

Authors:  Tian Liu; Fang Wang; Patrick LePochat; Jung-A A Woo; Mohammed Zaheen Bukhari; Kyung Woo Hong; Courtney Trotter; David E Kang
Journal:  Sci Rep       Date:  2017-09-14       Impact factor: 4.379

9.  Nucleoplasmic beta-actin exists in a dynamic equilibrium between low-mobility polymeric species and rapidly diffusing populations.

Authors:  Darin McDonald; Gustavo Carrero; Christi Andrin; Gerda de Vries; Michael J Hendzel
Journal:  J Cell Biol       Date:  2006-02-13       Impact factor: 10.539

10.  Imaging genome abnormalities in cancer research.

Authors:  Henry HQ Heng; Joshua B Stevens; Guo Liu; Steven W Bremer; Christine J Ye
Journal:  Cell Chromosome       Date:  2004-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.